Related Experiment Videos
No mourning for the conventional antipsychotics: the dawn of the atypical agents
1Medical University of South Carolina, Charleston 29425, USA.
The Annals of Pharmacotherapy
|February 11, 1999
Abstract:
As Markowitz et al. explain, the atypical antipsychotics should become the first-line agents for the treatment of schizophrenia. There is much to be learned about these drugs, but their displacement of the conventional antipsychotics will be a continuous process. The loss of the older drugs will not be mourned.